Wasatch Advisors LP Purchases 148,446 Shares of Billiontoone, Inc. $BLLN

Wasatch Advisors LP boosted its position in shares of Billiontoone, Inc. (NASDAQ:BLLN) by 40.2% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 518,084 shares of the company’s stock after buying an additional 148,446 shares during the period. Wasatch Advisors LP owned approximately 1.13% of Billiontoone worth $62,160,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in BLLN. Rossby Financial LCC bought a new stake in shares of Billiontoone during the 4th quarter worth approximately $25,000. Wells Fargo & Company MN acquired a new position in Billiontoone during the fourth quarter valued at approximately $76,000. Smartleaf Asset Management LLC bought a new stake in Billiontoone during the fourth quarter worth $80,000. Nano Cap New Millennium Growth Fund L P bought a new position in shares of Billiontoone in the 4th quarter valued at $82,000. Finally, Renaissance Capital LLC acquired a new position in shares of Billiontoone during the 4th quarter worth $201,000.

Billiontoone Stock Down 0.7%

NASDAQ:BLLN opened at $97.94 on Wednesday. The firm’s 50 day simple moving average is $116.72 and its 200 day simple moving average is $94.50. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. Billiontoone, Inc. has a one year low of $61.96 and a one year high of $150.44. The company has a market cap of $4.50 billion and a PE ratio of 139.91.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. The firm had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. On average, research analysts anticipate that Billiontoone, Inc. will post 0.92 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on BLLN. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday. BTIG Research decreased their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. Guggenheim initiated coverage on shares of Billiontoone in a research report on Monday, June 29th. They set a “buy” rating and a $125.00 price objective for the company. JPMorgan Chase & Co. cut their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 6th. Finally, Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd. Six analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $126.71.

Insider Buying and Selling at Billiontoone

In related news, SVP Bosch John Roderick Ten sold 1,416 shares of the stock in a transaction on Monday, June 29th. The stock was sold at an average price of $120.00, for a total value of $169,920.00. Following the completion of the sale, the senior vice president directly owned 33,552 shares in the company, valued at $4,026,240. This represents a 4.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shan Riku Sakakibara sold 4,000 shares of the firm’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $140.21, for a total value of $560,840.00. Following the transaction, the insider directly owned 200,000 shares of the company’s stock, valued at approximately $28,042,000. This represents a 1.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 202,049 shares of company stock worth $23,496,861. Company insiders own 50.22% of the company’s stock.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.